Identification of lymphatic pathway involved in the spreading of prostate cancer by fluorescence navigation approach with intraoperatively injected indocyanine green.

OBJECTIVE : The objective of this study was to identify lymphatic vessels draining from the prostate by using a fluorescence navigation (FN) system. METHODS : Fourteen subjects were candidates for radical retropubic prostatectomy (RRP) and pelvic lymph node dissection (PLND). After an indocyanine green solution was injected into the prostate during RRP, lymphatic vessels draining from the prostate were analyzed using a FN system. After PLND based on lymphatic mapping by the FN system (in vivo probing) was performed in the external iliac, obturator and internal iliac regions; the fluorescence of the removed lymph nodes (LNs) was analyzed on the bench (ex vivo probing). RESULTS : Under in vivo and ex vivo probing, the fluorescence intensity of internal iliac nodes was greater than that of external iliac or obturator nodes. CONCLUSION : The current study suggests that using a FN system after injecting indocyanine green is a safe and rational approach for detecting the lymphatic channel draining from the prostate. The major lymphatic pathway involved in the spreading of prostate cancer appears to relate to internal iliac LNs, which would mean that the standard PLND covering external iliac and obturator regions would not keep the cancer from spreading.

[1]  B. Trock,et al.  Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. , 2004, The Journal of urology.

[2]  F. Wawroschek,et al.  Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients. , 2007, The Journal of urology.

[3]  U. Studer,et al.  The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. , 2008, European urology.

[4]  W. Sega,et al.  Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. , 2008, European urology.

[5]  F. Wawroschek,et al.  The Sentinel Lymph Node Concept in Prostate Cancer – First Results of Gamma Probe-Guided Sentinel Lymph Node Identification , 1999, European Urology.

[6]  Mitsuharu Miwa,et al.  Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer , 2005, Breast cancer.

[7]  J. Gil-Vernet,et al.  Prostate cancer: anatomical and surgical considerations. , 1996, British journal of urology.

[8]  F. Burkhard,et al.  Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? , 2003, The Journal of urology.

[9]  A. Giuliano,et al.  Sentinel lymph node dissection and the current status of American trials on breast lymphatic mapping. , 2004, Seminars in oncology.

[10]  R. Elashoff,et al.  Sentinel Node Biopsy for Early-Stage Melanoma: Accuracy and Morbidity in MSLT-I, an International Multicenter Trial , 2005, Annals of surgery.

[11]  Jie Cai,et al.  Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. , 2004, The Journal of urology.

[12]  R. Cabanas,et al.  An approach for the treatment of penile carcinoma , 1977, Cancer.

[13]  F. Montorsi,et al.  Pelvic lymph node dissection in prostate cancer. , 2009, European urology.